FORTREA HOLDINGS INC. Operating Lease Right-of-Use Assets
FORTREA HOLDINGS INC. (FTRE) had Operating Lease Right-of-Use Assets of $56.00 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-02-26
- 2025-12-31: Operating Lease, Right-of-Use Asset $56.00M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $66.20M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $74.70M; Operating Lease, Right-of-Use Asset as first filed $78.20M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $50.00M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-12-31 | $56.00M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $66.20M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $74.70M 10-K · filed 2025-03-03 | $78.20M 10-K · filed 2024-03-13 |
| 2022-12-31 | $50.00M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |